Mimedx Group Inc (NASDAQ: MDXG) has a price-to-earnings ratio of 13.91x that is above its average ratio. Additionally, the 36-month beta value for MDXG is 1.97. There are mixed opinions on the stock, with 5 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for MDXG is 115.83M and currently, short sellers hold a 3.21% ratio of that float. The average trading volume of MDXG on February 28, 2025 was 630.70K shares.
MDXG) stock’s latest price update
Mimedx Group Inc (NASDAQ: MDXG)’s stock price has gone rise by 1.62 in comparison to its previous close of 8.01, however, the company has experienced a 3.69% increase in its stock price over the last five trading days. globenewswire.com reported 2025-02-27 that MARIETTA, Ga., Feb. 27, 2025 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that senior management will participate in the TD Cowen 45th Annual Health Care Conference.
MDXG’s Market Performance
Mimedx Group Inc (MDXG) has seen a 3.69% rise in stock performance for the week, with a -10.15% decline in the past month and a -11.52% plunge in the past quarter. The volatility ratio for the week is 4.83%, and the volatility levels for the past 30 days are at 3.45% for MDXG. The simple moving average for the last 20 days is -1.69% for MDXG’s stock, with a simple moving average of 8.81% for the last 200 days.
Analysts’ Opinion of MDXG
Many brokerage firms have already submitted their reports for MDXG stocks, with Cantor Fitzgerald repeating the rating for MDXG by listing it as a “Overweight.” The predicted price for MDXG in the upcoming period, according to Cantor Fitzgerald is $11 based on the research report published on July 02, 2024 of the previous year 2024.
Lake Street, on the other hand, stated in their research note that they expect to see MDXG reach a price target of $12. The rating they have provided for MDXG stocks is “Buy” according to the report published on March 07th, 2024.
Craig Hallum gave a rating of “Buy” to MDXG, setting the target price at $12 in the report published on October 27th of the previous year.
MDXG Trading at -7.08% from the 50-Day Moving Average
After a stumble in the market that brought MDXG to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -19.72% of loss for the given period.
Volatility was left at 3.45%, however, over the last 30 days, the volatility rate increased by 4.83%, as shares sank -10.06% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -13.77% lower at present.
During the last 5 trading sessions, MDXG rose by +3.69%, which changed the moving average for the period of 200-days by +12.43% in comparison to the 20-day moving average, which settled at $8.28. In addition, Mimedx Group Inc saw -15.38% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MDXG starting from Whitlow Ricci S, who sale 61,420 shares at the price of $8.28 back on Feb 13 ’25. After this action, Whitlow Ricci S now owns 403,019 shares of Mimedx Group Inc, valued at $508,558 using the latest closing price.
GARDNER PHYLLIS, the Former Director of Mimedx Group Inc, proposed sale 30,000 shares at $5.52 during a trade that took place back on Oct 10 ’24, which means that GARDNER PHYLLIS is holding shares at $165,637 based on the most recent closing price.
Stock Fundamentals for MDXG
Current profitability levels for the company are sitting at:
- 0.17 for the present operating margin
- 0.83 for the gross margin
The net margin for Mimedx Group Inc stands at 0.14. The total capital return value is set at 0.27. Equity return is now at value 62.47, with 39.66 for asset returns.
Based on Mimedx Group Inc (MDXG), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 67.13. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 28.11.
Currently, EBITDA for the company is 58.87 million with net debt to EBITDA at -1.7. When we switch over and look at the enterprise to sales, we see a ratio of 3.13. The receivables turnover for the company is 6.25for trailing twelve months and the total asset turnover is 1.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.10.
Conclusion
In conclusion, Mimedx Group Inc (MDXG) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
